1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > South Korea In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

South Korea In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

Summary

GlobalData’s new report, "South Korea In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture", provides key market data on the South Korea In Vitro Diagnostics market. The report provides value, in millions of US dollars within market segments - Immuno Chemistry, Clinical Chemistry, Infectious Diagnostics, Haematology, Microbiology Culture, Histology and Cytology and Genetic Testing.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- In Vitro Diagnostics market includes Immuno Chemistry, Clinical Chemistry, Infectious Diagnostics, Haematology, Microbiology Culture, Histology and Cytology and Genetic Testing.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for In Vitro Diagnostics market.
- Global corporate-level profiles of key companies operating within the South Korea In Vitro Diagnostics market.
- Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott Laboratories, bioMerieux S.A., Danaher Corporation, Ortho-Clinical Diagnostics Inc. Becton, Dickinson and Company, Bio-Rad Laboratories, Inc. and Others.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

South Korea In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 12
2.1 What Is This Report About? 12
2.2 In Vitro Diagnostics Market Segmentation 12
2.3 Definitions of Markets Covered in the Report 15
3 In Vitro Diagnostics Market, South Korea 28
3.1 In Vitro Diagnostics Market, South Korea, Revenue ($m), 2007-2021 28
3.2 In Vitro Diagnostics Market, South Korea, Revenue Mix ($m), 2014 30
3.3 In Vitro Diagnostics Market, South Korea, Category Contribution by Revenue ($m), 2014 31
3.4 In Vitro Diagnostics Market, South Korea, Category Comparison by Revenue ($m), 2007-2021 33
3.5 In Vitro Diagnostics Market, South Korea, Revenue ($m), 2007-2014 35
3.6 In Vitro Diagnostics Market, South Korea, Revenue ($m), 2014-2021 37
3.7 In Vitro Diagnostics Market, South Korea, Company Share by Revenue ($m), 2014 39
4 Clinical Chemistry Market, South Korea 41
4.1 Clinical Chemistry Market, South Korea, Revenue Mix ($m), 2014 41
4.2 Clinical Chemistry Market, South Korea, Segment Contribution (%), 2014 42
4.3 Clinical Chemistry Market, South Korea, Revenue ($m), 2007-2014 44
4.4 Clinical Chemistry Market, South Korea, Revenue ($m), 2014-2021 46
4.4.1 Clinical Chemistry Analyzers Market, South Korea, Revenue ($m), by Segment, 2007-2014 48
4.4.2 Therapeutic Drug Monitoring Market, South Korea, Revenue ($m), by Segment, 2007-2014 50
4.4.3 Urine Analysis Market, South Korea, Revenue ($m), by Segment, 2007-2014 52
4.4.4 Clinical Chemistry Analyzers Market, South Korea, Revenue ($m), by Segment, 2014-2021 54
4.4.5 Therapeutic Drug Monitoring Market, South Korea, Revenue ($m), by Segment, 2014-2021 56
4.4.6 Urine Analysis Market, South Korea, Revenue ($m), by Segment, 2014-2021 58
4.5 Clinical Chemistry Market, South Korea, Distribution Share by Revenue ($m), 2013-2014 60
4.6 Clinical Chemistry Market, South Korea, Company Share by Revenue ($m), 2014 61
5 Genetic Testing Market, South Korea 63
5.1 Genetic Testing Market, South Korea, Revenue Mix ($m), 2014 63
5.2 Genetic Testing Market, South Korea, Segment Contribution (%), 2014 64
5.3 Genetic Testing Market, South Korea, Revenue ($m), 2007-2014 65
5.4 Genetic Testing Market, South Korea, Revenue ($m), 2014-2021 67
5.5 Genetic Testing Market, South Korea, Distribution Share by Revenue ($m), 2013-2014 69
5.6 Genetic Testing Market, South Korea, Company Share by Revenue ($m), 2014 70
6 Haematology Market, South Korea 72
6.1 Haematology Market, South Korea, Revenue Mix ($m), 2014 72
6.2 Haematology Market, South Korea, Segment Contribution (%), 2014 73
6.3 Haematology Market, South Korea, Revenue ($m), 2007-2014 75
6.4 Haematology Market, South Korea, Revenue ($m), 2014-2021 77
6.4.1 Haematology Cell Counters Market, South Korea, Revenue ($m), by Segment, 2007-2014 79
6.4.2 Haematology Rapid Tests and POC Market, South Korea, Revenue ($m), by Segment, 2007-2014 81
6.4.3 Haematology Reagents Market, South Korea, Revenue ($m), by Segment, 2007-2014 83
6.4.4 Haemostasis Market, South Korea, Revenue ($m), by Segment, 2007-2014 85
6.4.5 Immunohaematology Market, South Korea, Revenue ($m), by Segment, 2007-2014 87
6.4.6 Haematology Cell Counters Market, South Korea, Revenue ($m), by Segment, 2014-2021 89
6.4.7 Haematology Rapid Tests and POC Market, South Korea, Revenue ($m), by Segment, 2014-2021 91
6.4.8 Haematology Reagents Market, South Korea, Revenue ($m), by Segment, 2014-2021 93
6.4.9 Haemostasis Market, South Korea, Revenue ($m), by Segment, 2014-2021 95
6.4.10 Immunohaematology Market, South Korea, Revenue ($m), by Segment, 2014-2021 97
6.5 Haematology Market, South Korea, Distribution Share by Revenue ($m), 2013-2014 99
6.6 Haematology Market, South Korea, Company Share by Revenue ($m), 2014 100
7 Histology And Cytology Market, South Korea 102
7.1 Histology And Cytology Market, South Korea, Revenue Mix ($m), 2014 102
7.2 Histology And Cytology Market, South Korea, Segment Contribution (%), 2014 103
7.3 Histology And Cytology Market, South Korea, Revenue ($m), 2007-2014 104
7.4 Histology And Cytology Market, South Korea, Revenue ($m), 2014-2021 106
7.5 Histology And Cytology Market, South Korea, Distribution Share by Revenue ($m), 2013-2014 108
7.6 Histology And Cytology Market, South Korea, Company Share by Revenue ($m), 2014 109
8 Immuno Chemistry Market, South Korea 111
8.1 Immuno Chemistry Market, South Korea, Revenue Mix ($m), 2014 111
8.2 Immuno Chemistry Market, South Korea, Segment Contribution (%), 2014 112
8.3 Immuno Chemistry Market, South Korea, Revenue ($m), 2007-2014 114
8.4 Immuno Chemistry Market, South Korea, Revenue ($m), 2014-2021 116
8.4.1 Anemia Tests Market, South Korea, Revenue ($m), by Segment, 2007-2014 118
8.4.2 Disease Specific Immunochemistry Market, South Korea, Revenue ($m), by Segment, 2007-2014 120
8.4.3 Endocrinology Tests Market, South Korea, Revenue ($m), by Segment, 2007-2014 122
8.4.4 IgE Allergy Blood Tests Market, South Korea, Revenue ($m), by Segment, 2007-2014 124
8.4.5 Immunochemistry Analyzers Market, South Korea, Revenue ($m), by Segment, 2007-2014 126
8.4.6 Immunochemistry Rapid Tests and POC Market, South Korea, Revenue ($m), by Segment, 2007-2014 128
8.4.7 Vitamins Tests Market, South Korea, Revenue ($m), by Segment, 2007-2014 130
8.4.8 Anemia Tests Market, South Korea, Revenue ($m), by Segment, 2014-2021 132
8.4.9 Disease Specific Immunochemistry Market, South Korea, Revenue ($m), by Segment, 2014-2021 134
8.4.10 Endocrinology Tests Market, South Korea, Revenue ($m), by Segment, 2014-2021 136
8.4.11 IgE Allergy Blood Tests Market, South Korea, Revenue ($m), by Segment, 2014-2021 138
8.4.12 Immunochemistry Analyzers Market, South Korea, Revenue ($m), by Segment, 2014-2021 140
8.4.13 Immunochemistry Rapid Tests and POC Market, South Korea, Revenue ($m), by Segment, 2014-2021 142
8.4.14 Vitamins Tests Market, South Korea, Revenue ($m), by Segment, 2014-2021 144
8.5 Immuno Chemistry Market, South Korea, Distribution Share by Revenue ($m), 2013-2014 146
8.6 Immuno Chemistry Market, South Korea, Company Share by Revenue ($m), 2014 147
9 Infectious Diagnostics Market, South Korea 149
9.1 Infectious Diagnostics Market, South Korea, Revenue Mix ($m), 2014 149
9.2 Infectious Diagnostics Market, South Korea, Segment Contribution (%), 2014 150
9.3 Infectious Diagnostics Market, South Korea, Revenue ($m), 2007-2014 152
9.4 Infectious Diagnostics Market, South Korea, Revenue ($m), 2014-2021 154
9.4.1 Infectious Diagnostics Rapid Tests and POC Market, South Korea, Revenue ($m), by Segment, 2007-2014 156
9.4.2 Infectious Diagnostics Rapid Tests and POC Market, South Korea, Revenue ($m), by Segment, 2014-2021 158
9.5 Infectious Diagnostics Market, South Korea, Distribution Share by Revenue ($m), 2013-2014 160
9.6 Infectious Diagnostics Market, South Korea, Company Share by Revenue ($m), 2014 161
10 Microbiology Culture Market, South Korea 163
10.1 Microbiology Culture Market, South Korea, Revenue Mix ($m), 2014 163
10.2 Microbiology Culture Market, South Korea, Segment Contribution (%), 2014 164
10.3 Microbiology Culture Market, South Korea, Revenue ($m), 2007-2014 166
10.4 Microbiology Culture Market, South Korea, Revenue ($m), 2014-2021 168
10.4.1 Microbiology Analyzers Market, South Korea, Revenue ($m), by Segment, 2007-2014 170
10.4.2 Microbiology Analyzers Market, South Korea, Revenue ($m), by Segment, 2014-2021 172
10.5 Microbiology Culture Market, South Korea, Distribution Share by Revenue ($m), 2013-2014 174
10.6 Microbiology Culture Market, South Korea, Company Share by Revenue ($m), 2014 175
11 Overview of Key Companies in South Korea, In Vitro Diagnostics Market 177
11.1 Siemens Healthcare 177
11.1.1 Company Overview 177
11.2 F. Hoffmann-La Roche Ltd. 177
11.2.1 Company Overview 177
11.3 Abbott Laboratories 177
11.3.1 Company Overview 177
11.4 Danaher Corporation 178
11.4.1 Company Overview 178
11.5 Bio-Rad Laboratories, Inc. 178
11.5.1 Company Overview 178
11.6 Becton, Dickinson and Company 178
11.6.1 Company Overview 178
11.7 bioMerieux S.A. 178
11.7.1 Company Overview 178
11.8 Alere Inc. 179
11.8.1 Company Overview 179
11.9 Sysmex Corporation 179
11.9.1 Company Overview 179
11.10 Hologic, Inc. 179
11.10.1 Company Overview 179
11.11 Toshiba Medical Systems Corporation 180
11.11.1 Company Overview 180
11.12 Guangzhou Dongsheng Biotech Co., Ltd. 180
11.12.1 Company Overview 180
11.13 Ortho-Clinical Diagnostics Inc. 180
11.13.1 Company Overview 180
11.14 Qiagen N.V. 180
11.14.1 Company Overview 180
11.15 Young in Frontier Co., Ltd. 181
11.15.1 Company Overview 181
12 In Vitro Diagnostics Market Pipeline Products 182
13 Financial Deals Landscape 188
13.1 Asset Transactions 188
13.1.1 Ferring Pharma to Acquire Novel Drug Delivery Technology from CTCBIO 188
13.2 Equity Offerings 189
13.2.1 NanoEnTek to Raise USD8.5 Million in Private Placement of Shares 189
13.3 Partnerships 190
13.3.1 Curetis Enters into Licensing Agreement with Acumen Research Labs for AcuSept 190
13.3.2 Seegene Enters into Co-Development Agreement with BD Life Sciences 191
13.3.3 OriGene Technologies Enters into Licensing Agreement with Diadexus 192
13.3.4 MdxHealth Enters into Licensing Agreement with Erasmus MC 193
13.3.5 Instrumentation Laboratory Company Enters into Partnership with Thermo Fisher Scientific 194
13.3.6 Sigma-Aldrich Enters into Distribution Agreement with LGC 195
13.3.7 OvaGene Oncology Enters into Agreement with Etta Healthcare 196
13.3.8 InTouch Health Enters into Agreement with iSchemaView 197
13.3.9 Lophius Biosciences Enters into Agreement with BLandH 198
13.3.10 Halozyme Therapeutics Enters into Co-Development Agreement with Ventana Medical Systems for Cancer Treatment 199
13.3.11 Courtagen Life Sciences Enter into Distribution Agreement with Pronto Diagnostics for Next Generation Sequencing Tests 200
13.3.12 DiaCarta Enters into Licensing Agreement with University of Potsdam for Colon Cancer Test 201
13.3.13 IncellDx Enters into Licensing Agreement with Claremont BioSolutions 202
13.3.14 Abbott Labs Enters into Agreement with Sekisui Diagnostics for Coagulation Testing 203
13.3.15 AngioDynamics Enters into Licensing Agreement with EmboMedics 204
13.3.16 Ion Beam Applications Enters into Distribution Agreement with Toshiba Medical Systems 205
13.3.17 Applied BioCode Expands Licensing Agreement with PerkinElmer for Barcoded Magnetic Bead Technology 206
13.3.18 Biocartis Enters into Licensing and Development Agreement with Microbiome 207
13.3.19 CBScientific Enters into Distribution Agreement with UTest 208
13.3.20 Vigilant Biosciences Enters into Distribution Agreement with BLandH 209
13.3.21 GeneThera Enters into Co-Development Agreement with Hudson Robotics 210
13.3.22 Nanospeed Enters into Distribution Agreement with DiaSys for Test4D 211
13.3.23 Genomic Vision Extends Agreement with Quest Diagnostics 212
13.3.24 Ortho-Clinical Enters into Distribution Agreement with Quotient for MosaiQ 213
13.3.25 Advanced Biological Labs, Inserm Transfert and Centre Hospitalier Universitaire Enter into Licensing Agreement for PyroVir software 215
13.3.26 BioMerieux Enters into Licensing Agreement with Astute Medical 216
13.3.27 MdxHealth Enters into Licensing Agreement with Oncgnostics for Epigenetic PCR Technology 217
13.3.28 NoemaLife Enters into Distribution Agreement with Horiba Medical 218
13.3.29 Thermo Fisher Scientific Enters into Co-Development Agreement with Samsung Electronics 219
13.3.30 Clinical Genomics Enters into Licensing Agreement with CSIRO 220
14 Recent Developments 221
14.1 Corporate Communications 221
14.1.1 Jun 10, 2015: Samsung Medical Center acquires Asia's first Leksell Gamma Knife Icon system 221
14.1.2 Jun 08, 2015: Celator Pharmaceuticals Announces Expansion of Clinical Study in Patients with Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia at High-Risk of Treatment-Related Mortality 221
14.2 Other Significant Developments 222
14.2.1 May 18, 2015: Macrogen Enters Exome Sequencing Analysis Service Provision Agreement with University College London 222
14.3 Product News 223
14.3.1 Nov 19, 2014: Seegene Receives US Patent for TOCE Technology 223
14.4 Strategy And Business Planning 224
14.4.1 Jul 08, 2015: QIAGEN Expands QIAsymphony Test Menu in Partnership with Seegene 224
15 Appendix 225
15.1 Research Methodology 226
15.1.1 Coverage 226
15.1.2 Secondary Research 226
15.1.3 Primary Research 226
15.1.4 Company Share Analysis 227
15.1.5 Distribution Share Analysis 227
15.2 GlobalData Consulting 227
15.3 Contact Us 227
15.4 Disclaimer 228

1.1 List of Tables
Table 1: In Vitro Diagnostics Market, South Korea, Revenue ($m), USD Constant, 2007-2021 29
Table 2: In Vitro Diagnostics Market, South Korea, Category Contribution by Revenue ($m), 2014 32
Table 3: In Vitro Diagnostics Market, South Korea, Category Comparison by Revenue ($m), USD Constant, 2007-2021 34
Table 4: In Vitro Diagnostics Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 36
Table 5: In Vitro Diagnostics Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 38
Table 6: In Vitro Diagnostics Market, South Korea, Company Share by Revenue ($m), USD Constant, 2014 40
Table 7: Clinical Chemistry Market, South Korea, Segment Contribution (%), 2014 43
Table 8: Clinical Chemistry Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 45
Table 9: Clinical Chemistry Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 47
Table 10: Clinical Chemistry Analyzers Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 49
Table 11: Therapeutic Drug Monitoring Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 51
Table 12: Urine Analysis Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 53
Table 13: Clinical Chemistry Analyzers Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 55
Table 14: Therapeutic Drug Monitoring Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 57
Table 15: Urine Analysis Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 59
Table 16: Clinical Chemistry Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2013-2014 60
Table 17: Clinical Chemistry Market, South Korea, Company Share by Revenue ($m), USD Constant, 2014 62
Table 18: Genetic Testing Market, South Korea, Segment Contribution (%), 2014 64
Table 19: Genetic Testing Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 66
Table 20: Genetic Testing Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 68
Table 21: Genetic Testing Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2013-2014 69
Table 22: Genetic Testing Market, South Korea, Company Share by Revenue ($m), USD Constant, 2014 71
Table 23: Haematology Market, South Korea, Segment Contribution (%), 2014 74
Table 24: Haematology Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 76
Table 25: Haematology Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 78
Table 26: Haematology Cell Counters Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 80
Table 27: Haematology Rapid Tests and POC Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 82
Table 28: Haematology Reagents Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 84
Table 29: Haemostasis Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 86
Table 30: Immunohaematology Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 88
Table 31: Haematology Cell Counters Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 90
Table 32: Haematology Rapid Tests and POC Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 92
Table 33: Haematology Reagents Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 94
Table 34: Haemostasis Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 96
Table 35: Immunohaematology Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 98
Table 36: Haematology Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2013-2014 99
Table 37: Haematology Market, South Korea, Company Share by Revenue ($m), USD Constant, 2014 101
Table 38: Histology And Cytology Market, South Korea, Segment Contribution (%), 2014 103
Table 39: Histology And Cytology Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 105
Table 40: Histology And Cytology Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 107
Table 41: Histology And Cytology Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2013-2014 108
Table 42: Histology And Cytology Market, South Korea, Company Share by Revenue ($m), USD Constant, 2014 110
Table 43: Immuno Chemistry Market, South Korea, Segment Contribution (%), 2014 113
Table 44: Immuno Chemistry Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 115
Table 45: Immuno Chemistry Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 117
Table 46: Anemia Tests Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 119
Table 47: Disease Specific Immunochemistry Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 121
Table 48: Endocrinology Tests Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 123
Table 49: IgE Allergy Blood Tests Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 125
Table 50: Immunochemistry Analyzers Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 127
Table 51: Immunochemistry Rapid Tests and POC Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 129
Table 52: Vitamins Tests Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 131
Table 53: Anemia Tests Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 133
Table 54: Disease Specific Immunochemistry Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 135
Table 55: Endocrinology Tests Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 137
Table 56: IgE Allergy Blood Tests Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 139
Table 57: Immunochemistry Analyzers Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 141
Table 58: Immunochemistry Rapid Tests and POC Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 143
Table 59: Vitamins Tests Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 145
Table 60: Immuno Chemistry Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2013-2014 146
Table 61: Immuno Chemistry Market, South Korea, Company Share by Revenue ($m), USD Constant, 2014 148
Table 62: Infectious Diagnostics Market, South Korea, Segment Contribution (%), 2014 151
Table 63: Infectious Diagnostics Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 153
Table 64: Infectious Diagnostics Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 155
Table 65: Infectious Diagnostics Rapid Tests and POC Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 157
Table 66: Infectious Diagnostics Rapid Tests and POC Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 159
Table 67: Infectious Diagnostics Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2013-2014 160
Table 68: Infectious Diagnostics Market, South Korea, Company Share by Revenue ($m), USD Constant, 2014 162
Table 69: Microbiology Culture Market, South Korea, Segment Contribution (%), 2014 165
Table 70: Microbiology Culture Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 167
Table 71: Microbiology Culture Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 169
Table 72: Microbiology Analyzers Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 171
Table 73: Microbiology Analyzers Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 173
Table 74: Microbiology Culture Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2013-2014 174
Table 75: Microbiology Culture Market, South Korea, Company Share by Revenue ($m), USD Constant, 2014 176
Table 76: In Vitro Diagnostics Market Pipeline Products 182
Table 77: Ferring Pharma to Acquire Novel Drug Delivery Technology from CTCBIO 188
Table 78: NanoEnTek to Raise USD8.5 Million in Private Placement of Shares 189
Table 79: Curetis Enters into Licensing Agreement with Acumen Research Labs for AcuSept 190
Table 80: Seegene Enters into Co-Development Agreement with BD Life Sciences 191
Table 81: OriGene Technologies Enters into Licensing Agreement with Diadexus 192
Table 82: MdxHealth Enters into Licensing Agreement with Erasmus MC 193
Table 83: Instrumentation Laboratory Company Enters into Partnership with Thermo Fisher Scientific 194
Table 84: Sigma-Aldrich Enters into Distribution Agreement with LGC 195
Table 85: OvaGene Oncology Enters into Agreement with Etta Healthcare 196
Table 86: InTouch Health Enters into Agreement with iSchemaView 197
Table 87: Lophius Biosciences Enters into Agreement with BLandH 198
Table 88: Halozyme Therapeutics Enters into Co-Development Agreement with Ventana Medical Systems for Cancer Treatment 199
Table 89: Courtagen Life Sciences Enter into Distribution Agreement with Pronto Diagnostics for Next Generation Sequencing Tests 200
Table 90: DiaCarta Enters into Licensing Agreement with University of Potsdam for Colon Cancer Test 201
Table 91: IncellDx Enters into Licensing Agreement with Claremont BioSolutions 202
Table 92: Abbott Labs Enters into Agreement with Sekisui Diagnostics for Coagulation Testing 203
Table 93: AngioDynamics Enters into Licensing Agreement with EmboMedics 204
Table 94: Ion Beam Applications Enters into Distribution Agreement with Toshiba Medical Systems 205
Table 95: Applied BioCode Expands Licensing Agreement with PerkinElmer for Barcoded Magnetic Bead Technology 206
Table 96: Biocartis Enters into Licensing and Development Agreement with Microbiome 207
Table 97: CBScientific Enters into Distribution Agreement with UTest 208
Table 98: Vigilant Biosciences Enters into Distribution Agreement with BLandH 209
Table 99: GeneThera Enters into Co-Development Agreement with Hudson Robotics 210
Table 100: Nanospeed Enters into Distribution Agreement with DiaSys for Test4D 211
Table 101: Genomic Vision Extends Agreement with Quest Diagnostics 212
Table 102: Ortho-Clinical Enters into Distribution Agreement with Quotient for MosaiQ 213
Table 103: Advanced Biological Labs, Inserm Transfert and Centre Hospitalier Universitaire Enter into Licensing Agreement for PyroVir software 215
Table 104: BioMerieux Enters into Licensing Agreement with Astute Medical 216
Table 105: MdxHealth Enters into Licensing Agreement with Oncgnostics for Epigenetic PCR Technology 217
Table 106: NoemaLife Enters into Distribution Agreement with Horiba Medical 218
Table 107: Thermo Fisher Scientific Enters into Co-Development Agreement with Samsung Electronics 219
Table 108: Clinical Genomics Enters into Licensing Agreement with CSIRO 220

1.2 List of Figures
Figure 1: In Vitro Diagnostics Market, South Korea, Revenue ($m), USD Constant, 2007-2021 28
Figure 2: In Vitro Diagnostics Market, South Korea, Revenue Mix ($m), 2014 30
Figure 3: In Vitro Diagnostics Market, South Korea, Category Contribution (%), 2014 31
Figure 4: In Vitro Diagnostics Market, South Korea, Category Comparison by Revenue ($m), USD Constant, 2007-2021 33
Figure 5: In Vitro Diagnostics Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 35
Figure 6: In Vitro Diagnostics Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 37
Figure 7: In Vitro Diagnostics Market, South Korea, Company Share (%) 2014 39
Figure 8: Clinical Chemistry Market, South Korea, Revenue Mix ($m), 2014 41
Figure 9: Clinical Chemistry Market, South Korea, Segment Contribution (%), 2014 42
Figure 10: Clinical Chemistry Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 44
Figure 11: Clinical Chemistry Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 46
Figure 12: Clinical Chemistry Analyzers Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 48
Figure 13: Therapeutic Drug Monitoring Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 50
Figure 14: Urine Analysis Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 52
Figure 15: Clinical Chemistry Analyzers Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 54
Figure 16: Therapeutic Drug Monitoring Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 56
Figure 17: Urine Analysis Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 58
Figure 18: Clinical Chemistry Market, South Korea, Company Share (%) 2014 61
Figure 19: Genetic Testing Market, South Korea, Revenue Mix ($m), 2014 63
Figure 20: Genetic Testing Market, South Korea, Segment Contribution (%), 2014 64
Figure 21: Genetic Testing Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 65
Figure 22: Genetic Testing Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 67
Figure 23: Genetic Testing Market, South Korea, Company Share (%) 2014 70
Figure 24: Haematology Market, South Korea, Revenue Mix ($m), 2014 72
Figure 25: Haematology Market, South Korea, Segment Contribution (%), 2014 73
Figure 26: Haematology Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 75
Figure 27: Haematology Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 77
Figure 28: Haematology Cell Counters Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 79
Figure 29: Haematology Rapid Tests and POC Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 81
Figure 30: Haematology Reagents Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 83
Figure 31: Haemostasis Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 85
Figure 32: Immunohaematology Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 87
Figure 33: Haematology Cell Counters Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 89
Figure 34: Haematology Rapid Tests and POC Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 91
Figure 35: Haematology Reagents Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 93
Figure 36: Haemostasis Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 95
Figure 37: Immunohaematology Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 97
Figure 38: Haematology Market, South Korea, Company Share (%) 2014 100
Figure 39: Histology And Cytology Market, South Korea, Revenue Mix ($m), 2014 102
Figure 40: Histology And Cytology Market, South Korea, Segment Contribution (%), 2014 103
Figure 41: Histology And Cytology Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 104
Figure 42: Histology And Cytology Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 106
Figure 43: Histology And Cytology Market, South Korea, Company Share (%) 2014 109
Figure 44: Immuno Chemistry Market, South Korea, Revenue Mix ($m), 2014 111
Figure 45: Immuno Chemistry Market, South Korea, Segment Contribution (%), 2014 112
Figure 46: Immuno Chemistry Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 114
Figure 47: Immuno Chemistry Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 116
Figure 48: Anemia Tests Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 118
Figure 49: Disease Specific Immunochemistry Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 120
Figure 50: Endocrinology Tests Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 122
Figure 51: IgE Allergy Blood Tests Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 124
Figure 52: Immunochemistry Analyzers Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 126
Figure 53: Immunochemistry Rapid Tests and POC Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 128
Figure 54: Vitamins Tests Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 130
Figure 55: Anemia Tests Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 132
Figure 56: Disease Specific Immunochemistry Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 134
Figure 57: Endocrinology Tests Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 136
Figure 58: IgE Allergy Blood Tests Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 138
Figure 59: Immunochemistry Analyzers Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 140
Figure 60: Immunochemistry Rapid Tests and POC Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 142
Figure 61: Vitamins Tests Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 144
Figure 62: Immuno Chemistry Market, South Korea, Company Share (%) 2014 147
Figure 63: Infectious Diagnostics Market, South Korea, Revenue Mix ($m), 2014 149
Figure 64: Infectious Diagnostics Market, South Korea, Segment Contribution (%), 2014 150
Figure 65: Infectious Diagnostics Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 152
Figure 66: Infectious Diagnostics Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 154
Figure 67: Infectious Diagnostics Rapid Tests and POC Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 156
Figure 68: Infectious Diagnostics Rapid Tests and POC Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 158
Figure 69: Infectious Diagnostics Market, South Korea, Company Share (%) 2014 161
Figure 70: Microbiology Culture Market, South Korea, Revenue Mix ($m), 2014 163
Figure 71: Microbiology Culture Market, South Korea, Segment Contribution (%), 2014 164
Figure 72: Microbiology Culture Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 166
Figure 73: Microbiology Culture Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 168
Figure 74: Microbiology Analyzers Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 170
Figure 75: Microbiology Analyzers Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 172
Figure 76: Microbiology Culture Market, South Korea, Company Share (%) 2014 175

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Competing in the Global Enteric Disease Testing Market

2016 Competing in the Global Enteric Disease Testing Market

  • $ 11500
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...

Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

  • $ 7500
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...

World Enteric Diseases Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

World Enteric Diseases Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

  • $ 7500
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.